Samik Basu

Company: Cabaletta Bio

Job title: Chief Scientific Officer

Seminars:

Mechanistic Insights of CABA-201 in Autoimmune Disease 11:30 am

• Clinical safety and efficacy of CABA-201 across different autoimmune diseases • Translational data highlighting the mechanism of action of CABA-201 NEW DATARead more

day: Day Two Track B, AM

Industry Leader’s Fireside Chat: Exploring Present Advancements & Challenges in the Cell Therapies for Autoimmune Disease Space 8:30 am

An interactive panel discussion from the industry leaders to set the scene on the autoimmune space. Ask your questions live to understand the expert’s thoughts on key topics including: • How has this rapidly evolving space advanced this year? • Discussing the latest findings and what this means for the cell therapy for autoimmune field…Read more

day: Day One AM